Allergic reactions to anaesthetics in surgery: current challenges and perspectives.

Q2 Pharmacology, Toxicology and Pharmaceutics
Drug metabolism and personalized therapy Pub Date : 2026-06-03 eCollection Date: 2026-09-01 DOI:10.1515/dmpt-2026-0008
Maria Zofia Lisiecka, Joanna Luczak
{"title":"Allergic reactions to anaesthetics in surgery: current challenges and perspectives.","authors":"Maria Zofia Lisiecka, Joanna Luczak","doi":"10.1515/dmpt-2026-0008","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study was conducted to assess the current state of issues related to AR to anaesthetics used in surgical procedures.</p><p><strong>Contents: </strong>A literature review of scientific publications in allergology and anaesthesiology was performed, evaluating the allergenic profile of modern anaesthetics and analysing approaches to preventing AR during surgery.</p><p><strong>Summary: </strong>Currently, the most commonly used local anaesthetics are amides, including lidocaine, bupivacaine, articaine, mepivacaine, ropivacaine, and levobupivacaine. These are considered safer in terms of allergenicity compared to their ester-based predecessors - novocaine, benzocaine, and tetracaine - as their metabolites rarely act as allergens. Among general anaesthetics, intravenous agents such as propofol, midazolam, etomidate, and ketamine, as well as inhalational agents including sevoflurane, isoflurane, desflurane, and xenon, are widely used. These are generally safer than their predecessor, thiopental, with xenon currently exhibiting the highest safety profile due to its inert chemical properties. Muscle relaxants have the highest allergenic potential, as their mechanism of action - blocking acetylcholine receptors - can lead to cell damage and the release of immune-stimulating substances. The only representative of depolarising muscle relaxants is succinylcholine, while non-depolarising agents include atracurium, cisatracurium, vecuronium, rocuronium, pancuronium, and mivacurium.</p><p><strong>Outlook: </strong>Preventive measures to reduce the risk of AR include: a detailed patient history and diagnostic testing using skin tests, provocation tests, and/or blood tests for immunoglobulin E (IgE); replacement of the allergenic drug with a safer alternative if an allergy is confirmed; close monitoring for allergic manifestations during surgery, with professional preparedness for resuscitation in cases of anaphylaxis; postoperative patient monitoring to detect potential delayed AR; documentation of all AR for future reference. The findings of this study may be applied in clinical practice to mitigate the risks of AR associated with anaesthetic use during surgical interventions.</p>","PeriodicalId":11332,"journal":{"name":"Drug metabolism and personalized therapy","volume":" ","pages":"125-135"},"PeriodicalIF":0.0000,"publicationDate":"2026-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug metabolism and personalized therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/dmpt-2026-0008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: This study was conducted to assess the current state of issues related to AR to anaesthetics used in surgical procedures.

Contents: A literature review of scientific publications in allergology and anaesthesiology was performed, evaluating the allergenic profile of modern anaesthetics and analysing approaches to preventing AR during surgery.

Summary: Currently, the most commonly used local anaesthetics are amides, including lidocaine, bupivacaine, articaine, mepivacaine, ropivacaine, and levobupivacaine. These are considered safer in terms of allergenicity compared to their ester-based predecessors - novocaine, benzocaine, and tetracaine - as their metabolites rarely act as allergens. Among general anaesthetics, intravenous agents such as propofol, midazolam, etomidate, and ketamine, as well as inhalational agents including sevoflurane, isoflurane, desflurane, and xenon, are widely used. These are generally safer than their predecessor, thiopental, with xenon currently exhibiting the highest safety profile due to its inert chemical properties. Muscle relaxants have the highest allergenic potential, as their mechanism of action - blocking acetylcholine receptors - can lead to cell damage and the release of immune-stimulating substances. The only representative of depolarising muscle relaxants is succinylcholine, while non-depolarising agents include atracurium, cisatracurium, vecuronium, rocuronium, pancuronium, and mivacurium.

Outlook: Preventive measures to reduce the risk of AR include: a detailed patient history and diagnostic testing using skin tests, provocation tests, and/or blood tests for immunoglobulin E (IgE); replacement of the allergenic drug with a safer alternative if an allergy is confirmed; close monitoring for allergic manifestations during surgery, with professional preparedness for resuscitation in cases of anaphylaxis; postoperative patient monitoring to detect potential delayed AR; documentation of all AR for future reference. The findings of this study may be applied in clinical practice to mitigate the risks of AR associated with anaesthetic use during surgical interventions.

手术中麻醉药的过敏反应:当前的挑战和观点。
导论:本研究旨在评估外科手术中麻醉药致AR相关问题的现状。内容:对变态反应学和麻醉学的科学出版物进行了文献回顾,评估了现代麻醉药的致敏特征,并分析了手术中预防AR的方法。摘要:目前最常用的局部麻醉剂是酰胺类药物,包括利多卡因、布比卡因、阿替卡因、甲哌卡因、罗哌卡因和左布比卡因。由于它们的代谢物很少作为过敏原,因此在致敏性方面,它们被认为比它们的酯基前体——诺佛卡因、苯佐卡因和丁卡因——更安全。在全身麻醉剂中,静脉注射药物如异丙酚、咪达唑仑、依托咪酯和氯胺酮,以及吸入药物包括七氟烷、异氟烷、地氟烷和氙,被广泛使用。这些通常比它们的前身硫喷妥钠更安全,由于其惰性化学性质,氙目前显示出最高的安全性。肌肉松弛剂具有最高的致敏潜力,因为它们的作用机制——阻断乙酰胆碱受体——会导致细胞损伤和释放免疫刺激物质。去极化肌肉松弛剂的唯一代表是琥珀酰胆碱,而非去极化药物包括阿曲库铵、顺阿曲库铵、维库溴铵、罗库溴铵、潘库溴铵和米维库溴铵。展望:降低AR风险的预防措施包括:详细的患者病史和使用皮肤试验、激发试验和/或免疫球蛋白E (IgE)血液检测的诊断测试;如果确认过敏,用更安全的替代药物替代致敏药物;术中密切监测过敏表现,在过敏反应病例中做好复苏的专业准备;术后患者监测以发现潜在的延迟性AR;所有AR的文档以备将来参考。本研究的结果可能应用于临床实践,以减轻手术干预过程中与麻醉剂使用相关的AR风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug metabolism and personalized therapy
Drug metabolism and personalized therapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
2.30
自引率
0.00%
发文量
35
期刊介绍: Drug Metabolism and Personalized Therapy (DMPT) is a peer-reviewed journal, and is abstracted/indexed in relevant major Abstracting Services. It provides up-to-date research articles, reviews and opinion papers in the wide field of drug metabolism research, covering established, new and potential drugs, environmentally toxic chemicals, the mechanisms by which drugs may interact with each other and with biological systems, and the pharmacological and toxicological consequences of these interactions and drug metabolism and excretion. Topics: drug metabolizing enzymes, pharmacogenetics and pharmacogenomics, biochemical pharmacology, molecular pathology, clinical pharmacology, pharmacokinetics and drug-drug interactions, immunopharmacology, neuropsychopharmacology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书